Qube Research & Technologies Ltd - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 258 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q1 2024$260,087
-85.0%
16,545
-88.3%
0.00%
-100.0%
Q3 2023$1,732,812
+216.2%
140,879
+313.2%
0.01%
+150.0%
Q2 2023$547,955
+84.3%
34,098
+99.7%
0.00%
+100.0%
Q1 2023$297,311
-63.2%
17,077
-80.4%
0.00%
-75.0%
Q4 2022$806,994
+244.9%
87,337
+353.7%
0.00%
+100.0%
Q1 2022$234,000
+6.4%
19,252
+141.5%
0.00%
-77.8%
Q1 2020$220,000
-49.5%
7,972
-46.5%
0.01%
-35.7%
Q4 2019$436,00014,9120.01%
Other shareholders
NEOGENOMICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,615,513$13,166,0009.25%
First Light Asset Management, LLC 2,715,487$22,131,0002.58%
PERKINS CAPITAL MANAGEMENT INC 202,550$1,651,0001.71%
Greenhouse Funds LLLP 1,395,035$11,370,0001.25%
EMERALD ADVISERS, LLC 1,213,353$9,889,0000.51%
Bullseye Asset Management LLC 108,272$883,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 959,858$7,823,0000.45%
OAK FAMILY ADVISORS, LLC 88,604$722,0000.36%
MPM BioImpact LLC 135,573$1,105,0000.31%
Fernwood Investment Management, LLC 70,285$573,0000.25%
View complete list of NEOGENOMICS INC shareholders